Moderna's total assets for Q3 2024 were $15.80B, an increase of 0.78% from the previous quarter. MRNA total liabilities were $3.88B for the fiscal quarter, a -2.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.